Pulike Biological Engineering Balance Sheet Health
Financial Health criteria checks 6/6
Pulike Biological Engineering has a total shareholder equity of CN¥2.6B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.1B and CN¥451.6M respectively. Pulike Biological Engineering's EBIT is CN¥72.9M making its interest coverage ratio -12.2. It has cash and short-term investments of CN¥566.5M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -12.2x |
| Cash | CN¥566.46m |
| Equity | CN¥2.64b |
| Total liabilities | CN¥451.59m |
| Total assets | CN¥3.09b |
Recent financial health updates
Recent updates
Pulike Biological Engineering's (SHSE:603566) Weak Earnings May Only Reveal A Part Of The Whole Picture
Sep 04
Pulike Biological Engineering, Inc. (SHSE:603566) Looks Just Right With A 34% Price Jump
May 21Need To Know: The Consensus Just Cut Its Pulike Biological Engineering, Inc. (SHSE:603566) Estimates For 2024
Apr 28Why Investors Shouldn't Be Surprised By Pulike Biological Engineering, Inc.'s (SHSE:603566) Low P/E
Mar 21Pulike Biological Engineering (SHSE:603566) Seems To Use Debt Quite Sensibly
Feb 28Financial Position Analysis
Short Term Liabilities: 603566's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥411.3M).
Long Term Liabilities: 603566's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥40.3M).
Debt to Equity History and Analysis
Debt Level: 603566 is debt free.
Reducing Debt: 603566 had no debt 5 years ago.
Debt Coverage: 603566 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 603566 has no debt, therefore coverage of interest payments is not a concern.